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Pancreatic ﬁstula continues to be a common complication following PD. This study seeks to identify clinical factors which may
predictpancreatic ﬁstula(PF)andevaluate theeﬀectofPFonoutcomesfollowingpancreaticoduodenectomy (PD).Weperformed
a retrospective analysis of a clinical database at an academic tertiary care hospital with a high volume of pancreatic surgery.
Five hundred ten consecutive patients underwent PD, and PF occurred in 46 patients (9%). Perioperative mortality of patients
with PF was 0%. Forty-ﬁve of 46 PF (98%) closed without reoperation with a mean time to closure of 34 days. Patients who
developed PF showed a higher incidence of wound infection, intra-abdominal abscess, need for reoperation, and hospital length
of stay. Multivariate analysis demonstrated an invaginated pancreatic anastomosis and closed suction intraperitoneal drainage
were associated with PF whereas a diagnosis of chronic pancreatitis and endoscopic stenting conferred protection. Development
of PF following PD in this series was predicted by gender, preoperative stenting, pancreatic anastomotic technique, and pancreas
pathology. Outcomes in patients with PF are remarkable for a higher rate of septic complications, longer hospital stays, but in this
study, no increased mortality.
Copyright © 2009 C. Max Schmidt et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Despite major advances in pancreatic surgery, pancreatic
ﬁstula (PF) continues to be a common complication after
pancreaticoduodenectomy (PD) occurring in 9–14% of
patients even at high volume centers [1–10]. Classical risk
factors associated with PF have been described in the
literature and include the following: patient demographics,
pancreatic gland texture, pancreatic duct size, pathology of
periampullary lesion, anastomotic technique, and surgeon
volume [11–20]. This complication with PD continues to
occur despite an acknowledged improvement in other types
of postoperative complications and declining mortality rates
in most large surgical series. As most surgeons realize,
the technical challenges of sewing the pancreas to the
intestinal tract are formidable. Despite these diﬃculties, the
overwhelmingmajorityofpancreaticanastomoses(80–90%)
heals without signiﬁcant leakage. If substantial progress in
reducing the rate of PF is to be made, improved understand-
ing of the risk factors which predispose to ﬁstula formation
seems essential. Identifying which glands in which patients
areathighriskforaleakcantriggermodiﬁcationsinsurgical
technique, drainage, and postoperative care to minimize
ﬁstula formation. In this study we asked the following
questions: ﬁrst, what preoperative and perioperative factors
might predict PF following pancreaticoduodenectomy? Sec-
ond, what is the eﬀect of PF on outcomes following pancre-
aticoduodenectomy? To answer these questions, we analyzed2 HPB Surgery
our experience with PD at a high-volume pancreatic referral
center and then examined the eﬀect of these variables on the
incidence of PF and the clinical outcomes in this group of
patients.
2.MaterialsandMethods
This is a retrospective review of a case series of consecutive
patients who underwent pancreaticoduodenectomy for a
broad range of periampullary and pancreatic pathologies
between January 1980 and June 2002 at Indiana University
Medical Center, a tertiary care academic training hospital
in Indianapolis, Indiana. Only patients who had pancre-
aticoduodenectomy with a remnant, viable pancreatic tail
were included for analysis. Patients who underwent total
pancreatectomy due to positive resection margins or those
who had undergone previous distal pancreatic resections
prior to their pancreaticoduodenectomy were excluded from
this study. Pancreatic ﬁstula (PF) was deﬁned during the
broad range of years in this experience by several deﬁnitions.
From 1980 to 1985, a PF was deﬁned as >10mL of amylase-
rich ﬂuid per day from a surgically placed drain or through
a cutaneous site (around a penrose drain) after postoperative
day 8 and lasting for at least 8 days. From 1985–2002
our deﬁnition was >50mL/day of amylase rich ﬂuid after
postoperative day 11 and lasting for at least 11 days. Since
2005 at our institution, we have used the International Study
Group for Pancreatic Fistula (ISGPF) guidelines deﬁning
pancreatic ﬁstula as any measurable volume of ﬂuid on
or after postoperative day 3 with amylase content greater
than 3 times the serum amylase activity (21). Based on
a careful review of the patients medical records during
their hospital treatment and postoperative clinical follow-
up, pancreatic ﬁstula grades A, B, or C were assigned to
each ﬁstula identiﬁed as deﬁned in the ISGPF guidelines
(see Table 1). Data were collected and reported in strict
compliance with patient conﬁdentiality guidelines put forth
by the Indiana University-Purdue University Indianapolis
institutional review board.
2.1. Data Collection. All patients had a baseline history and
physical examination recorded. For preoperative variables
twelve patient symptoms, physical signs, and associated
conditions were included in the database including the fol-
lowing: abdominal pain, back pain, nausea/vomiting, diar-
rhea, abdominal tenderness, jaundice, diabetes, pancreatitis,
abdominal mass, organomegaly, hemepositive stools, and
weight loss. The diagnosis of jaundice was based on the pres-
ence of scleral icterus on physical examination. The presence
of new onset diabetes mellitus was deﬁned as the existence
of glucose intolerance necessitating diet modiﬁcation, oral
hyperglycemic drug, or insulin supplementation within two
years of the diagnosis of a periampullary pathologic disorder
requiring operation. The diagnosis of diarrhea was made if
patients reported three or more bowel movements per day or
if the total volume of their movements in a day was 0.5 liters
or greater. Weight loss was quantiﬁed by patient history at
the time of the preoperative visit.
Table 1: Parameters utilized to grade post-operative pancreatic
ﬁstulas (POPFs) (21).
Grade AB C
Clinical condition Well Often well Ill appearing/bad
Speciﬁc treatment∗ No Yes/No Yes
US/CT (if
obtained)
Negative Negative/Positive Positive
Persistent drainage
(after 3 weeks)† No Usually yes Yes
Reoperation No No Yes
Death related to
POPF
No No Probably yes
Signs of infection No Yes Yes
Sepsis No No Yes
Readmission No Yes/No Yes
US = Ultrasonography; CT = computed tomography scan.
∗Partial (peripheral) or total parenteral nutrition, antibiotics, enteral
nutrition, somatostatin analogue, and/or minimally invasive drainage.
†With or without a drain in situ.
Nine preoperative serum chemistries (total bilirubin,
alkaline phosphatase, SGOT, total protein, albumin, amy-
lase, glucose, calcium and phosphorous), ﬁve hematologic
parameters(hematocrit,hemoglobin,whitebloodcellcount,
prothrombin time, and partial thromboplastin time), and
three serum tumor marker values (CEA, CA-19-9, and CA-
125) were obtained from routine blood draws either in the
preoperative clinic or during a hospitalization close to the
time of operation.
Eleven perioperative variables including pre-operative
biliary stenting (endoscopic or percutaneous transhepatic),
pre-operative transfusion, pre-operative total parenteral
nutrition (TPN), pre-operative bowel preparation, esti-
mated intra-operative blood loss (mL), intra- and post-
operative transfusions, operative time (minutes), type of
resection (standard versus pylorus preservation), type of
pancreaticojejunostomy (invagination or end-to-side duct to
mucosa), type of intraperitoneal drains used (penrose or
closed suction Jackson-Pratt drains), and gastrostomy tube
placement were identiﬁed from the patient medical records,
anesthesiologist’s records, and the operative reports.
All specimens were reviewed by the staﬀ pathologist
at Indiana University Medical Center with the majority of
specimensalsoundergoingasecondaryreviewbyadedicated
pancreatic pathologist. Histopathologic diagnosis, tumor
size, tumor diﬀerentiation (well, moderate, poor, none),
lymph node status (positive, negative), and surgical margin
status (positive, negative) were routinely reported. Margins
analyzed included the common bile duct, pancreatic neck,
and duodenum or stomach. Retroperitoneal (Uncinate)
soft tissue margins were inconsistently analyzed early in
this series (1980–2002), but since 2002, at our facility,
standardized retroperitoneal margin assessment and analysis
have been carried out based on AJCC guidelines (37).
Clinical outcomes variables that were assessed included the
following: in-hospital mortality, overall complications, and
speciﬁc complications such as cardiopulmonary, delayedHPB Surgery 3
gastric emptying (DGE), sepsis, wound infection, intra-
abdominal abscess, hemorrhage, and hospital length of stay
(LOS). Delayed gastric emptying was deﬁned in this cohort
as the inability to take a regular diet after postoperative
day no. 10. Survival was determined from the most recent
encounter at Indiana University Hospital and was cross-
referencedwiththeClarianCancerRegistryDatabaseandthe
Social Security Database.
2.2. Operative Techniques. Twelve surgeons operated on
patients included in this study who underwent either
pylorus preserving or classic (hemigastrectomy) pancre-
aticoduodenectomy. Truncal vagotomy was performed in
most patients undergoing hemigastrectomy. Reconstruction
was undertaken with an isoperistaltic limb of jejunum
in retrocolic fashion and anastomosed with an end-to-
side pancreaticojejunostomy, followed by an end-to-side
choledochojejunostomyandan(antecolicorretrocolic)end-
to-sideduodenojejunostomyorgastrojejunostomy.Thepan-
creaticojejunostomy was performed using a duct-to-mucosa
anastomosis (n = 453) or, alternatively, an invaginated
anastomosis (n = 52) based on surgeon preference. Of
the 52 invaginated anastomoses in this series, 6 surgeons
used this technique. Only one surgeon used this technique
predominately, accounting for 63% of their total PD. During
this period at our institution, thirty-ﬁve anatomoses (7%)
were constructed using pancreatic duct stents. There were no
pancreaticogastrostomies used. The pancreaticojejunostomy
and choledochojejunostomy were drained routinely with
Penrose drains to gravity or closed suction drains. Drainage
around Penrose drains was collected with an ostomy skin
appliance. Prophylactic octreotide was not routinely used.
Finally, some patients in this series underwent elective gas-
trostomy for postoperative decompression and alimentation.
2.3. Statistical Analysis. Statistical associations between cate-
goricalfactorswereassessedusingtheFisher’sExactTest.The
association of categorical factors with survival was assessed
using the Kaplan-Meier Method (KM) and was tested using
the log-rank test. The association of continuous variables
with survival was analyzed using a Cox’s proportional
hazards regression model and tested via the Wald Test.
Median values of continuous data were compared using the
Kruskal-Wallis Test. Analyses were performed with a forward
stepwise logistic regression model selection procedure where
the probability of inclusion of a factor in the model was set
at 20% and the probability of removal factor from the model
was 20%. Statistical signiﬁcance was set at P ≤ .05.
3. Results
Of 510 patients undergoing pancreaticoduodenectomy, 46
patients (9%) had a PF. The mean age was the same in
patients with PF (58 years; range 30–79) compared to those
without PF (58 years; range 15–93). Two hundred eighty
fourpatients(56%)weremale.Sixty-ﬁve patientsunderwent
pancreaticoduodenectomy in the 1980s with the remainder
being performed from 1990 and 2000. The incidence of
Table 2: Relationship of measured perioperative variables with the
developmentofaPFin510patientswhohadpancreaticoduodenec-
tomy.
Variable
PF No. PF P-value
(n = 46) (n = 464)
Pre-op stent 43% (20) 41% (191) P = NS
Endoscopic 20% (9) 29% (134) P = .22
Percutaneous 24% (11) 12% (57) P = .04
Pre-op transfusion 6% (2) 5% (18) P = NS
Pre-op TPN 16% (5) 22% (78) P = NS
Pre-op bowel preparation∗ 43% (20) 50% (237) P = .02
Yes 30% (14) 45% (212)
No 13% (6) 5% (25)
Blood loss (median) 1300mL 1300mL P = NS
Transfusions (median) 1U 1U P = NS
Operative time (median) 7h o u r s 5h o u r s P<. 001
Type of resection P = NS
Pylorus preserving 61% (28) 50% (231)
Classic 39% (18) 50% (233)
Type of anastomosis P<. 001
Duct-to-mucosa 74% (34) 90% (419)
Invaginated 26% (12) 9% (40)
Other (3)/unknown (2) 0 (0) 1% (5)
Drain type P =<. 001
Penrose 17% (8) 50% (233)
Closed suction 83% (38) 50% (231)
G-tube placement 22% (10) 14% (64) P = NS
PF: Pancreatic ﬁstula; ∗Pre-op bowel preparation information was available
inonly257patients.():Totalnumberofpatientsineachgroupwithdeﬁned
variable.
PF as a function of time by decade (1980’s = 9%; 1990’s =
6%; 2000’s = 1 0 % )o rb yy e a r( P = NS) did not change
signiﬁcantly over the course of the study period. Pancreatic
ﬁstula was more common in males, with this diﬀerence
approaching statistical signiﬁcance in univariate analysis,
(P = .06).
Of the twelve preoperative patient symptoms tracked,
none were associated with a signiﬁcant diﬀerence in the rate
of ﬁstula formation (data not shown). Notably, a preopera-
tive diagnosis of diabetes was present in a greater proportion
of patients who did not have PF; however, this result was
not statistically signiﬁcant. Only serum glucose showed a
signiﬁcant association (P = .04) with PF formation. Serum
glucose tended to be higher in patients who did not have a
PF corroborating the trend in diabetes incidence previously
noted.
Eleven perioperative variables that were evaluated are
shown in Table 2. Preoperative biliary stenting was done in
211 patients, 68 of whom had percutaneous transhepatic
biliary stenting, and 143 had endoscopic stenting. Preopera-
tivebiliarystenting(combinedpercutaneousandendoscopic
groups) showed no signiﬁcant diﬀerence in PF rates when
compared to patients who were not preoperatively stented4 HPB Surgery
(9% stented group (20/211) versus 8% without stenting
(26/299)). When subclassiﬁed into percutaneous transhep-
atic or endoscopic stenting however, a signiﬁcantly higher
incidence of PF was found in the percutaneous transhepatic
stent group, 16% (11/68) compared to endoscopic stent
group 6% (9/143) (P = .04). Preoperative blood transfusion
or preoperative TPN were not associated with PF formation.
Information about preoperative mechanical bowel prepa-
ration was not tracked in the latter half of our series;
however, among patients in whom preoperative mechanical
bowel preparation status was known, a signiﬁcantly higher
incidence of PF was identiﬁed in patients who did not
undergo mechanical bowel preparation (19% (6/31) versus
6% (14/226), P<. 02) implying that mechanical bowel
preparation may be protective against PF. Average and
median blood loss and transfusion requirement were not
signiﬁcantly associated with PF. Median operative time,
however, was comparatively longer in the PF group (7 hours
versus 5 hours, P<. 001). Pylorus preserving pancre-
aticoduodenectomy was performed in 259 patients (51%)
and classic pancreaticoduodenectomy was performed in 251
patients (49%). The incidence of PF was not signiﬁcantly
diﬀerent according to operation performed (11%, (28/259)
PPPD versus 7% (18/251) classic). In general, two types of
pancreaticojejunostomy reconstruction were performed. A
duct-to-mucosa anastomosis was performed in 453 patients,
and an invaginated anastomosis was performed in 52
patients. In the remaining 5 patients, 3 underwent Peustow
reconstruction of the remnant, and in 2, the reconstruction
was unclear based upon operative records. There was a more
than 3X higher incidence of PF in invaginated anastomoses
(23%) when compared to duct-to mucosa (7%), P<. 001.
Two types of drainage were employed over the course of
these operations, closed suction drainage to a bulb suction
device usually of the Jackson-Pratt type, and passive/gravity
drainage with a Penrose drain. Closed suction drainage was
used in 269 patients (53%) and passive drainage with a
Penrose drain was used in 241 patients (47%) with both
techniques used continuously throughout this study. There
was a signiﬁcantly higher incidence of PF in patients who
underwent closed suction drainage (14%) compared to
passive Penrose drainage (3%), P<. 001. Placement of
a gastrostomy tube was done in 74 patients and was not
associated with a comparatively diﬀerent PF rate.
Incidence of PF was evaluated according to underlying
pancreas pathology (Table 3). The development of a PF
was much more common in patients with the diagnosis of
duodenal (15%) or Ampullary adenocarcinoma (17%) (P =
.01 and .06, resp.). Alternatively, patients with a diagnosis
of pancreatitis were less likely to develop a PF (P = .02).
Characteristics of the tumor pathology in patients with
periampullary adenocarcinoma are provided in Table 4.S i z e
of pancreatic lesion measured in longest diameter, tumor
diﬀerentiation, surgical margin status, and lymph node
status were assessed. There was no statistically signiﬁcant
diﬀerence in any of these variables and the incidence of PF
formation.
Clinical outcomes are given in Table 5.T h e r ew a sa4 %
mortality rate in patients who did not have PF and no
Table 3: Primary pathologic diagnosis in 510 patients having pan-
creaticoduodenectomy.
Variable
PF No. PF P-value
(n = 46) (n = 464)
Periampullary Ca 65% (30) 56% (264) P = NS
Pancreatic 28% (13) 40% (188) P = NS
Ampullary 17% (8) 8% (39) P = .06
Duodenal 15% (7) 5% (24) P = .01
Bile duct 4% (2) 3% (13) P = NS
Pancreatitis 9% (4) 23% (106) P = .02
Cystic neoplasms 11% (5) 12% (53) P = NS
IPMN 4% (2) 11% (47) P = NS
Mucinous cystadenoma 2% (1) 1% (4) P = NS
Serous cystadenoma 4% (2) 0.4% (2) P = NS
Islet cell neoplasms 6% (3) 3% (16) P = NS
Functional 4% (2) 1% (6) P = NS
Nonfunctional 4% (2) 1% (6) P = NS
Trauma 4% (2) 1% (6) P = NS
Other 4% (2) 4% (19) P = NS
Table 4: Tumor size and histopathologic characteristics in the 294
patients in this series with periampullary malignancies and their
relationship to PF formation.
Variable
PF No. PF P-value
(n = 30) (n = 264)
Diameter (mean ± SD) 3.2 ± 1.0cm 3.1 ± 1.5cm P = NS
Tumor diﬀerentiation P = NS
Well 8% (2) 8% (22)
Moderate 48% (14) 39% (102)
Poor 22% (7) 31% (82)
None 22% (7) 22% (58)
Surgical margin status P = NS
Negative 80% (24) 83% (219)
Positive 20% (6) 17% (45)
Lymph node status P = NS
Negative 43% (13) 43% (114)
Positive 57% (17) 57% (150)
mortality in patients who had a PF, a diﬀerence that was
not statistically signiﬁcant. There were no diﬀerences in
rate of complications between patients who had a PF when
compared to those who did not; however, the total number
of complications (number of complications per patient) was
greater in patients who developed a PF. In addition, the
type of complications varied according to whether or not
a PF was present. The incidence of sepsis (P<. 001),
wound infection (P<. 001), and intra-abdominal abscess
(P<. 001) were signiﬁcantly higher in the PF group. The
26% reoperation rate for patients with PF was signiﬁcantly
higher than the 0.4% rate in patients without PF. Of the
twelve reoperations done in the PF group, eleven were done
for complications of the PF and only one was done for aHPB Surgery 5
persistent ﬁstula which lasted for greater than 4 months. Six
reoperations were done prior to the diagnosis of PF for sepsis
or a visceral pseudoaneurysm, and six were done in patients
following the diagnosis of PF for complications including
the following: wound dehiscence (1), poor ﬁstula drainage
with sepsis (3), breakdown of the hepaticojejunostomy (1),
and persistent ﬁstula >4 months (1). The diagnosis of PF
was made on average on postoperative day 8 and these
patients experienced longer lengths of hospital stay. The
median length of stay in the PF group was 25 days, whereas
it was only 12 days in the no PF group (P<. 001).
Based upon international study group for pancreatic ﬁstula
(ISGPF) grading guidelines, this series included 10 grade A
ﬁstulas, 23 grade B ﬁstulas, and 13 grade C ﬁstulas [21].
Forty-ﬁve of 46 PF (98%) closed without reoperation with
a mean time to closure of 34 days (range 3–93 days). Twenty-
three patients (all grade 13 grade C ﬁstulas and 10 grade B
ﬁstulas) were treated with antibiotics. Ten patients (5 grade
C and 5 grade B ﬁstulas) were treated with octreotide. This
timing ofclosurewasnot signiﬁcantly diﬀerentwith/without
octreotide treatment (39 ± 5v e r s u s2 5± 5) or with/without
antibiotic treatment (36 ± 5v e r s u s2 9± 6). Thirty-six
patients required TPN for an average of 32 days (range
5–90 days). Time to closure was not aﬀected by nutrition
route (enteral versus parenteral), daily PF output, or the
level of amylase/lipase in the PF ﬂuid analysis. Average
daily ﬁstula output was 163 ± 26 cc but with a wide
range (50–2300 cc). Computed tomography (CT) directed
percutaneousdrainageofanintra-abdominalﬂuidcollection
was required in 11 of 46 patients with a PF. In seven of these
patients,theﬁstulagrewbacteriaonroutineculture.Notably,
there was a trend of delayed ﬁstula closure when patients
requiredpercutaneousdrainageofanyintra-abdominalﬂuid
collectionpostoperatively(42±7da yswithv ersus30±5da ys
without, P = .09).
A multivariate analysis was performed of all parameters
with a forward stepwise logistic regression model (Tables
6(a)–6(c)). This analysis indicated that independent pre-
dictive factors for the formation of a PF were as follows:
invaginated anastomosis (OR 3.30, P = .01) and closed
suction drainage (OR 2.24, P = .05). A diagnosis of
pancreatitis (OR 0.22, P = .05) and preoperative endoscopic
biliary stenting (OR 0.34, P = .05) were independent
protective factors against PF. Because the type of drain
was highly correlated with individual surgeon, in a separate
assessment we performed a multivariate analysis excluding
drain type (Table 6(b)). In this analysis, invaginated pancre-
aticojejunostomy (OR 4.56, P = .002) remained a signiﬁcant
predictive factor of PF and the diagnosis of pancreatitis (OR
0.22, P = .05) remained an independent protective factor.
While the presence of an endoscopic stent did not reach
signiﬁcance, the presence of a preoperative percutaneous
transhepatic biliary stent (OR 2.43, P = .07) approached
signiﬁcance.
A multivariate analysis was also performed on the
subgroup of patients with periampullary adenocarcinomas
(Table 6(c)). The only independent predictor of PF forma-
tion in this group was an invaginated pancreaticojejunos-
tomy (OR 11.8, P = .0002). Female gender (OR 0.238,
Table 5: Morbidity, mortality, and length of hospital stay in 510
patients who had pancreaticoduodenectomy.
Outcomes
PF No. PF P-value
(n = 46) (n = 470)
Mortality 0% 4% P = NS
LOS (median) 25 days 12 days P<. 001
Complications (# patients) 17 (37) 176 (37) P = NS
Cardiopulmonary 8 (17) 69 (15) P = NS
DGE 3 (7) 35 (7) P = NS
Sepsis 10 (21) 22 (5) P<. 001
Wound infection 9 (20) 17 (4) P<. 001
Intra-abdominal abscess 7 (15) 10 (2) P<. 001
Hemorrhage 3 (7) 15 (3) P = NS
Reoperation∗ 12 (26) 2 (<1) P<. 005
Reoperation (prior to diagnosis) 6 (13) NA
Reoperation (following diagnosis) 6 (13) NA
PF:Pancreaticﬁstula;Mortality:In-hospitalmortality;LOS:Hospitallength
of stay; DGE: Delayed gastric emptying; ∗Reoperation was broken down
into reoperations done prior to the diagnosis of PF and following the
diagnosis of PF; only one PF was reoperated on for failure to close within
4m o n t h s .
Table 6
(a) Multivariate analysis of factors predictive of pancreatic ﬁstula.
Predictive factor Odds ratio P-value
Invaginated
pancreaticojejunostomy
3.30 .01
Closed suction drainage 2.24 .05
Diagnosis of pancreatitis 0.22 .05
Pre-op endoscopic
biliary stent
0.34 .05
(b) Multivariate analysis of factors predictive of pancreatic ﬁstula
excluding transperitoneal drain type.
Predictive factor Odds ratio P-value
Invaginated
pancreaticojejunostomy
4.56 .002
Pre-op PTB stent 2.43 .07
Diagnosis of pancreatitis 0.22 .05
PTB: Percutaneous transhepatic biliary
(c) Multivariate analysis of factors predicting pancreatic ﬁstula in 294
patients with periampullary adenocarcinoma subgroup.
Predictive factor Odds ratio Stats
Invaginated
pancreaticojejunostomy
11.78 .0002
Pre-op endoscopic
biliary stent
0.194 .04
Gender (Female) 0.238 .03
Pre-op diabetes 0.146 .07
P = .03) and endoscopic stent (OR 0.194, P = .04)
were independent protective factors against PF formation.6 HPB Surgery
Diabetes (OR 0.146, P = .07) demonstrated a trend as a
protective factor against PF formation.
4. Discussion
In this study, we report our experience with PF in a series
of 510 consecutive pancreaticoduodenectomies performed
over a 22-year period. Our incidence of PF was 9% which
appears to be comparable to the PF rate of 9–14% reported
in other specialized centers [1–10]. It is diﬃcult to compare
the incidence and severity of PF without standardization of
the diagnosis, terms, and severity of this complication. It is
hopeful that the standardized deﬁnitions of PF as put forth
by the ISGPF will likely allow for more equitable comparison
among institutions [21].
The risk of PF formation appears to be multifactorial
involving demographic, preoperative, intraoperative, and
pathologic factors. One prior study has reported that male
sex was a signiﬁcant predictor of PF [22]. In this study, male
genderonlyapproachedsigniﬁcanceasaunivariatepredictor
of PF formation in the overall group of patients undergoing
pancreaticoduodenectomy. In our periampullary adenocar-
cinoma subgroup analysis, females had a lower incidence
of PF and these results showed a trend as an independent
predictor of PF on multivariate analysis. Advanced age cited
by some as predictive of PF was not recognized as a predictor
in this series [23, 24].
A higher incidence of PF was identiﬁed in patients
who did not undergo mechanical bowel preparation. This
association to our knowledge has not been reported before
and so is an intriguing ﬁnding. Perhaps the absence of
intestinal succus or stool in the colon minimizes pressure
in the jejunum limb translating into reduced PF rates.
This association was not signiﬁcant on multivariate analysis.
Intraoperative blood loss cited by some as predictive was
also not recognized as a signiﬁcant factor in this series
[23, 24]. Type of pancreaticojejunostomy anastomosis has
also been cited by others in the literature to be a predictor
of PF [25]. This study showed that the type of pancreati-
cojejunostomy reconstruction (invaginated versus end-to-
side) was signiﬁcantly associated with PF in both the whole
group and periampullary adenocarcinoma subanalysis. A
recent metaanalysis addressing this particular association
found a higher incidence of PF in patients who had
invaginated pancreaticojejunostomy (26%) versus a duct-to-
mucosa (16%) type of anastomosis [25]. These ﬁndings are
in contrast to a randomized control trial of 144 patients
performed in Italy by Bassi et al. [26] which showed
no signiﬁcant diﬀerence between invaginated and duct-to-
mucosa anastomoses in PD. Our pancreaticobiliary group
is currently participating in a prospective randomized trial
with Thomas Jeﬀerson University to determine whether or
not there is a diﬀerence in PF rate between invaginated
and duct-to-mucosa pancreaticojejunostomy in PD. The
results of this trial should be forthcoming later this year
(2009).
Preoperative biliary stenting has been an area where
some groups show an association with PF. A study from
Hopkins suggests that preoperative stenting is associated
with an increased risk of PF formation [27]. Our data is
variable according to whether the preoperative stenting was
endoscopic or percutaneous. On the one hand, preoperative
endoscopic stents are actually protective in our subgroup
of patients with periampullary adenocarcinoma, while those
patients who had preoperative percutaneous transhepatic
biliary (PTB) stenting showed an increased risk of PF
formation. Other authors have also shown that preoperative
endoscopic stenting decreases the incidence of postoperative
PF [28].
Our study also suggests that closed suction drainage
may be a predictor of PF formation. The Memorial Sloan
Kettering group has shown a lower incidence of PF in
patients who did not have intraperitoneal drainage following
PD[29].InourseriesbothPenrosedrainsandclosedsuction
drains were used and the Penrose drain group showed a
lower incidence of PF formation. This ﬁnding implies that
active suction drainage may have a deleterious eﬀect on PF
formation. A confounding factor in our study was that the
Penrose type drain was used largely by the highest volume
surgeon in our series who also had a comparably low PF rate.
Drain type covaried so tightly with individual surgeons such
that it was not possible to separate whether drain type or
individual surgeon was more predictive in our multivariate
model.
One factor which appears to be a consistent is that
the texture of the gland is signiﬁcantly associated with
PF formation. Yeo et al. [19] stratiﬁed patients in a trial
according to the texture of the gland and found that patients
with a ﬁrmer texture gland had a lower incidence of PF.
Other studies have also supported the association between
soft pancreatic gland texture and the risk of PF [25, 30, 31].
Our data is indirectly supportive that the texture of the gland
is predictive of PF formation in those patients with both
duodenal and ampullary adenocarcinomas, who often have a
normal (i.e., soft) gland texture; both had a higher incidence
of PF formation in our series but intraoperative assessment
of the gland at the time of operation was not available in our
retrospective database. Other investigators have associated
a small pancreatic duct as a contributing factor to PF
formation[22,32].Pancreaticductsizewasnotprospectively
tracked in our series of patients although it should be noted
that this particular variable is often diﬃcult to separate
between soft textures of the gland because typically soft
glands also have small pancreatic ducts [19, 22].
Although not addressed speciﬁcally in our analysis,
individualsurgeonstendtovarywidelyintheirpostoperative
rate of PF. In particular, two speciﬁc surgeons in this series
(out of the 12 participants) had signiﬁcantly diﬀerent PF
rates from the average of their remaining peers. One surgeon
had a signiﬁcantly lower incidence of PF (4% compared to
14% for all others combined, P<. 001) while the other
surgeon had a signiﬁcantly higher incidence of PF (18%
versus 8% for all others combined, P = .04). While these
diﬀerences were accounted for, in part, by the diﬀerences
in pancreatic pathology in each surgeon’s cohort, this issue
brings up the surgeon as a signiﬁcant variable in the
incidence of PF formation.HPB Surgery 7
Pancreatic ﬁstula remains the “Achilles heel” of pan-
creaticoduodenectomy and novel approaches continue to
be put forward to reduce its incidence [33–36]. Although
historically, PF were associated with a mortality rate of 20
to 40% [3, 7, 8], current advances in radiologic imaging and
interventional radiologic techniques, antibiotics, and critical
care medicine have considerably reduced the mortality rates
from PF. Our data is consistent with this trend since in
our series of patients with PF, there were no in-hospital
mortalities. Nonetheless, PFs continues to cause signiﬁcant
morbidity, prolonged hospital stay, and increased hospital
cost. Our data supports these observations since patients
withPFhadagreatertotalnumberofcomplications,ahigher
incidence of septic complications, and a higher reoperation
rate. In addition, our patient’s length of hospital stay was
twice that of patients who did not have a PF.
Based on univariate analyses, gender, diabetes, preop-
erative glucose level, length of operation, bowel prepa-
ration, biliary stenting (endoscopic versus percutaneous),
anastomotictechnique(invaginatedversusduct-to-mucosa),
intraperitoneal drain choice (passive/gravity versus closed-
suction), and pathology (pancreatitis, duodenal cancer) may
inﬂuencePFformation.Inmultivariateanalyses,invaginated
anastomosis, closed suction drainage, and percutaneous
biliary stenting all increased the risk of PF while pancreatitis,
endoscopic biliary stenting, and female gender conferred
protection against PF. The inﬂuence of the individual
surgeon on PF is also an extremely important factor to
consider although diﬃcult to separate from other variables
such as gender, pancreatic pathology, or biliary stenting in a
retrospectively designed study.
In conclusion, in this series the development of PF fol-
lowing pancreaticoduodenectomy was predicted by demo-
graphics (gender), preoperative procedures (biliary stent-
ing), intraoperative technique (anastomosis, drainage, indi-
vidual surgeon), and pancreatic pathology (pancreatitis).
Outcomes in patients with PF are remarkable for a higher
rate of septic complications, an increased incidence of
reoperations, and a longer hospital stay without signiﬁcant
diﬀerenceinoverallmortalityrate.Preoperativebiliarystent-
ing, type of pancreaticoenteric anastomosis, and intraperi-
toneal drain usage are controllable factors in PF formation
that surgeons should continue to investigate to reduce its
incidence following PD.
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